Inventor · disambiguated record
Aaron Craig Burns
Also filed as: BURNS AARON · BURNS AARON CRAIG
18 granted patents·18 pending applications·37 citations·filing 2015–2025
91Inventor score
Top patents by PatentIndex Score
36 records- 0196US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0296US11091495B2Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Aug 17, 2021·4 cites·26 claims
- 0392US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 0492US11220509B2Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Granted Jan 11, 2022·2 cites·27 claims
- 0591US10647715B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2019·Granted May 12, 2020·10 cites·9 claims
- 0684US11479551B2MTA-cooperative PRMT5 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Oct 25, 2022·1 cites·30 claims
- 0782US11548888B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Jan 10, 2023·1 cites·9 claims
- 0882US11434247B1Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Granted Sep 6, 2022·2 cites·24 claims
- 0982US2025282787A1SUBSTITUTED IMIDAZO[1,2-c]PYRIMIDINES AS PRC2 INHIBITORSMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1080US12371435B2Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Jul 29, 2025·0 cites·20 claims
- 1179US10125130B2Cycloalkyl-linked diheterocycle derivativesPFIZER·Filed 2017·Granted Nov 13, 2018·2 cites·21 claims
- 1278US2025145633A1Substituted furanopyrimidine compounds as pde1 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1377US12304915B2SOS1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted May 20, 2025·0 cites·81 claims
- 1477US2024309020A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1575US12006325B2Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Jun 11, 2024·0 cites·20 claims
- 1675US2025270220A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1773US10676471B2Cycloalkyl-linked diheterocycle derivativesPFIZER·Filed 2019·Granted Jun 9, 2020·0 cites·2 claims
- 1872US2023054883A1MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1968US11492351B2MTA-cooperative PRMT5 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Nov 8, 2022·0 cites·27 claims
- 2068US2020262837A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2167US11702418B2SOS1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Jul 18, 2023·0 cites·72 claims
- 2267US2024391882A1Substituted QuinoxalinesMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2366US11485738B2Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2019·Granted Nov 1, 2022·0 cites·18 claims
- 2466US2025382290A1Salts of sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2560US12252493B2Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancerMIRATI THERAPEUTICS INC·Filed 2020·Granted Mar 18, 2025·0 cites·27 claims
- 2660US2025179082A1Imidazo[1,2-c]pyrimidine derivatives as prc2 inhibitors for treating cancerMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2759US2024228510A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2859US2024368153A1Aminopyridine-based MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2959US2025059182A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3059US2020308170A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3158US2019040055A1Cycloalkyl-Linked Diheterocycle DerivativesPFIZER·Filed 2018·Application pending·0 cites
- 3257US2024208912A1MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3354US2023101312A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3453US2023279025A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3550US12421228B2Naphthyridine derivatives as PRC2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 23, 2025·0 cites·29 claims
- 3648US2017050958A1Cycloalkyl-Linked Diheterocycle DerivativesPFIZER·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aaron Craig Burns files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →